Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells
H Modi, T McDonald, S Chu, JK Yee… - Blood, The Journal …, 2007 - ashpublications.org
Abstract Increased levels of Bcr-Abl expression in chronic myelogenous leukemia (CML)
cells are associated with disease progression and imatinib (IM) resistance. However, it is not …
cells are associated with disease progression and imatinib (IM) resistance. However, it is not …
[引用][C] Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells
H MODI, T MCDONALD, SU CHU, JK YEE… - Blood, 2007 - pascal-francis.inist.fr
Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib
sensitivity of transformed human hematopoietic cells CNRS Inist Pascal-Francis CNRS …
sensitivity of transformed human hematopoietic cells CNRS Inist Pascal-Francis CNRS …
[PDF][PDF] Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells
H Modi, T McDonald, S Chu, JK Yee, SJ Forman… - BLOOD, 2007 - academia.edu
Chronic myeloid leukemia (CML) is a hematopoietic stem cell disorder characterized by a
balanced translocation between chromosomes 9 and 22, also known as the Philadelphia …
balanced translocation between chromosomes 9 and 22, also known as the Philadelphia …
Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells
H Modi, T McDonald, S Chu, JK Yee, SJ Forman… - …, 2007 - pubmed.ncbi.nlm.nih.gov
Increased levels of Bcr-Abl expression in chronic myelogenous leukemia (CML) cells are
associated with disease progression and imatinib (IM) resistance. However, it is not clear if …
associated with disease progression and imatinib (IM) resistance. However, it is not clear if …
Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells.
H Modi, T McDonald, S Chu, JK Yee, SJ Forman… - Blood, 2007 - europepmc.org
Abstract Increased levels of Bcr-Abl expression in chronic myelogenous leukemia (CML)
cells are associated with disease progression and imatinib (IM) resistance. However, it is not …
cells are associated with disease progression and imatinib (IM) resistance. However, it is not …
[HTML][HTML] Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells
H Modi, T McDonald, S Chu, JK Yee, SJ Forman… - Blood, 2007 - ncbi.nlm.nih.gov
Abstract Increased levels of Bcr-Abl expression in chronic myelogenous leukemia (CML)
cells are associated with disease progression and imatinib (IM) resistance. However, it is not …
cells are associated with disease progression and imatinib (IM) resistance. However, it is not …
[HTML][HTML] Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells
H Modi, T McDonald, S Chu, JK Yee, SJ Forman… - Blood, 2007 - Elsevier
Abstract Increased levels of Bcr-Abl expression in chronic myelogenous leukemia (CML)
cells are associated with disease progression and imatinib (IM) resistance. However, it is not …
cells are associated with disease progression and imatinib (IM) resistance. However, it is not …
[PDF][PDF] Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells
H Modi, T McDonald, S Chu, JK Yee, SJ Forman… - BLOOD, 2007 - researchgate.net
Chronic myeloid leukemia (CML) is a hematopoietic stem cell disorder characterized by a
balanced translocation between chromosomes 9 and 22, also known as the Philadelphia …
balanced translocation between chromosomes 9 and 22, also known as the Philadelphia …
Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells.
H Modi, T McDonald, S Chu, JK Yee, SJ Forman… - Blood, 2007 - europepmc.org
Abstract Increased levels of Bcr-Abl expression in chronic myelogenous leukemia (CML)
cells are associated with disease progression and imatinib (IM) resistance. However, it is not …
cells are associated with disease progression and imatinib (IM) resistance. However, it is not …
[PDF][PDF] Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells
H Modi, T McDonald, S Chu, JK Yee, SJ Forman… - BLOOD, 2007 - academia.edu
Chronic myeloid leukemia (CML) is a hematopoietic stem cell disorder characterized by a
balanced translocation between chromosomes 9 and 22, also known as the Philadelphia …
balanced translocation between chromosomes 9 and 22, also known as the Philadelphia …